The shortage of EpiPen 300 mcg adrenaline auto-injectors has been resolved in Australia.

Medicine shortage resolved

23 January 2019

Consumers and health professionals are advised that the shortage of EpiPen 300 mcg adrenaline auto-injectors has been resolved.

The sponsor, Alphapharm Pty Ltd (trading as Mylan Australia), has confirmed that there is sufficient supply of EpiPen 300 mcg adrenaline auto-injectors to meet current patient needs in Australia.